Full Event Guide

Take a look at what the 2023 meeting explored:

•  Lead the race to clinic and patient access powered by specialized T-cell redirection, cross reactive T-cell engagers and small molecule regulated protein switches to increase potency and enhance their anti-tumor activity
• Solve the potential activation and expansion obstacles in translating gamma delta T cells from preclinical findings to clinical applications
• Boost the potential of Gamma Delta T Cell Therapies with engineering approaches that address a wide range of antigens, and target metabolic pathways in gamma delta T cells